Oncolytics Biotech
Immunotherapy platform for GI tumors
Oncolytics is developing pelareorep, a unique immunotherapy with broad antitumor potential
Company details
- Sector
- Healthcare & Pharma
- Categories
- pharmaceutical industry
- Address
- Calgary, Canada
- Website
- oncolyticsbiotech.com
Services
- pelareorep development — Investigational immunotherapy for GI cancers
Industries served
pharmaceuticals
Highlights
- Fast Track Designation from FDA for metastatic pancreatic ductal adenocarcinoma
- Clinical trials showing 45% 1‑year survival in first‑line mPDAC
- Clinical trials showing 16.6 months progression‑free survival in second‑line KRAS‑mutant mCRC
Reviews
No reviews yet.
Domain and WHOIS record
- Domain
- oncolyticsbiotech.com
- Registrar
- Network Solutions, LLC
- Registered
- 24 Feb 2000
- Expires
- 24 Feb 2028
- Record updated
- 26 Dec 2024
- Name servers
- ns41.worldnic.com, ns42.worldnic.com
- DNSSEC
- Not signed